血管光滑肌疾病中的N6-甲基氨酸修饰:一篇评论
Chengjun Huang1, Xianping Long1, Ranzun Zhao1
1Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Journal of vascular research
|October 7, 2025
概括
N6-甲基氨酸 (m6A) 修饰调节血管光滑肌细胞 (VSMC) 功能,并与心血管疾病有关. 对m6A修饰的进一步研究可能会揭示VSMC功能障碍的新治疗点.
科学领域:
- 血管生物学 血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子医学是分子医学.
背景情况:
- 血管光滑肌细胞 (VSMC) 功能障碍是主要血管疾病的基础,包括动脉样硬化和高血压.
- N6-甲基氨酸 (m6A) 修饰正在成为血管系统内VSMC功能的关键调节者.
研究的目的:
- 研究m6A修饰及其相关酶在由VSMC功能障碍驱动的血管疾病中的作用.
- 探索m6A修饰作为治疗VSMC功能障碍相关疾病的潜在治疗标.
主要方法:
- 该研究将涉及检查m6A修饰影响VSMC生物学的机制.
- 在疾病模型中分析m6A相关酶及其对VSMC功能的影响.
主要成果:
- m6A修饰通过RNA代谢调节影响了关键的VSMC过程,包括增殖,迁移,表型切换和亡.
- 有证据表明,m6A修饰模式与血管疾病的进展之间存在重要联系.
结论:
- m6A修饰在VSMC生物学和心血管疾病中起着至关重要的作用.
- 准m6A修饰为管理VSMC功能障碍和相关血管疾病提供了一个有希望的治疗途径.
相关概念视频
RNA Editing
9.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K
Atherosclerosis I: Introduction
916
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
916
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K


